Teikoku Pharma USA

The overall transdermal patch market, which comprises four segments – hormone replacement therapy, pain management, heart disease and neurological disorders – is expected to see modest growth of 2.4%,

California attorney general Xavier Becerra has announced settlements with firms including Teva that are worth nearly $70m, as part of action taken over so-called ‘pay for delay’ deals that delayed c

The global market for transdermal patch products, which is divided into five segments – cardiovascular disease, neurological disorders, hormone replacement therapies, pain management and genitourinary

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c